Tennessee Senate Bill SB1767

Tennessee 2025-2026 Regular Session

• Introduced: 1/20/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68, relative to health.

Impact

If enacted, SB1767 would have profound implications for public health regulations in Tennessee. The prohibition on administering mRNA vaccines would not only limit the state's response to communicable diseases but also challenge the widely adopted vaccination protocols that rely on mRNA technologies. This would signal a significant shift in how health interventions are regulated at the state level, particularly in response to pandemics. Critics fear this measure could lead to decreased vaccination rates, resulting in heightened public health crises. Meanwhile, proponents see it as a necessary step to safeguard medical practitioners and individuals from potential harm associated with these vaccines.

Summary

Senate Bill 1767, known as the Tennessee mRNA Pharmaceutical Sovereignty and Safety Act, seeks to amend various sections of the Tennessee Code concerning health regulations. The bill aims to prohibit the administration of mRNA vaccines and similar pharmaceutical interventions within the state, which the sponsors argue carry significant health risks and unproven efficacy. The bill references numerous health concerns linked to mRNA technology, including cardiovascular issues, respiratory complications, and adverse neurological effects, particularly in vulnerable populations such as children. Acknowledging the need for public health, the legislation emphasizes a cautious approach towards new medical interventions, advocating for patient safety and informed consent.

Sentiment

The sentiment surrounding SB1767 is highly polarized. Supporters, including certain political factions and advocacy groups, argue that the bill is essential for protecting individual health freedoms and preventing government overreach into personal medical decisions. They perceive the current reliance on mRNA technology as risky and unverified. Conversely, opponents, including public health officials and medical professionals, express concern that the bill could undermine collective health efforts and foster misinformation about vaccination, which they argue is safe and effective. This division highlights the ongoing tensions between personal choice and public health responsibilities.

Contention

One of the notable points of contention regarding SB1767 is the scientific evidence it relies upon to support its claims about the dangers of mRNA vaccines. Opponents question the validity of the studies cited in the bill, arguing that they do not reflect the consensus within the medical community regarding mRNA technology's safety and efficacy. Moreover, healthcare providers express worries about the potential legal implications they may face under this law if it is enacted, particularly regarding the standard practice of vaccination. The debate encapsulates broader societal conflicts about health autonomy, safety, and the role of government in personal health decisions.